PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
High Beta - Max Sharpe Optimization
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


LLY 31.9%NVO 31.9%ACGL 16.7%AVGO 7.6%NVDA 6%SMCI 3.2%ELF 2.7%EquityEquity
PositionCategory/SectorTarget Weight
ACGL
Arch Capital Group Ltd.
Financial Services
16.70%
AVGO
Broadcom Inc.
Technology
7.60%
ELF
e.l.f. Beauty, Inc.
Consumer Defensive
2.70%
LLY
Eli Lilly and Company
Healthcare
31.90%
NVDA
NVIDIA Corporation
Technology
6%
NVO
Novo Nordisk A/S
Healthcare
31.90%
SMCI
Super Micro Computer, Inc.
Technology
3.20%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in High Beta - Max Sharpe Optimization, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
-3.00%
14.40%
High Beta - Max Sharpe Optimization
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Sep 22, 2016, corresponding to the inception date of ELF

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
1.92%0.88%15.58%20.89%12.50%11.34%
High Beta - Max Sharpe Optimization-5.65%-9.24%-3.00%17.01%44.87%N/A
LLY
Eli Lilly and Company
4.98%3.64%2.49%15.51%42.71%30.25%
NVO
Novo Nordisk A/S
-3.92%-5.70%-36.24%-29.34%22.71%16.94%
ACGL
Arch Capital Group Ltd.
0.81%1.86%1.31%17.03%16.32%17.27%
AVGO
Broadcom Inc.
-6.09%-6.37%52.19%77.51%51.28%39.13%
NVDA
NVIDIA Corporation
-13.13%-19.25%11.92%68.30%79.60%73.16%
SMCI
Super Micro Computer, Inc.
-11.91%-19.44%-56.48%-59.52%57.21%21.95%
ELF
e.l.f. Beauty, Inc.
-25.58%-25.48%-49.15%-44.95%37.83%N/A
*Annualized

Monthly Returns

The table below presents the monthly returns of High Beta - Max Sharpe Optimization, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-3.96%-5.65%
202417.48%20.28%8.38%-3.27%10.06%9.84%-7.89%4.96%-4.50%-1.73%0.38%-2.23%59.45%
20233.10%2.50%11.60%7.04%13.93%7.90%3.85%10.66%-5.28%0.68%8.33%2.45%88.76%
2022-11.60%1.32%10.60%-8.53%3.18%-3.97%6.13%-8.10%-3.13%12.34%10.67%-0.25%5.20%
20216.09%3.04%-3.61%4.20%6.67%11.52%4.06%8.36%-7.08%14.30%6.27%3.58%72.18%
20203.90%-4.90%-1.88%7.01%6.78%4.82%-0.21%6.42%1.17%-7.64%8.97%7.62%35.15%
20194.62%6.28%6.11%-3.71%-6.52%5.50%-1.06%3.97%0.90%4.71%3.42%6.36%33.94%
20183.69%-4.81%-2.37%-1.83%5.45%-2.33%8.27%4.43%0.02%-8.77%3.06%-3.98%-0.53%
20172.73%3.25%1.39%2.06%5.87%0.64%2.67%3.58%1.97%2.53%1.76%-0.94%31.05%
2016-2.95%-7.27%0.22%7.06%-3.45%

Expense Ratio

High Beta - Max Sharpe Optimization has an expense ratio of 0.00%, indicating no management fees are charged. Below you can find the expense ratios of portfolio funds side-by-side and effortlessly compare their relative costs.


The portfolio doesn't hold funds that charge fees

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of High Beta - Max Sharpe Optimization is 7, meaning it’s performing worse than 93% of other portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of High Beta - Max Sharpe Optimization is 77
Overall Rank
The Sharpe Ratio Rank of High Beta - Max Sharpe Optimization is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of High Beta - Max Sharpe Optimization is 77
Sortino Ratio Rank
The Omega Ratio Rank of High Beta - Max Sharpe Optimization is 66
Omega Ratio Rank
The Calmar Ratio Rank of High Beta - Max Sharpe Optimization is 99
Calmar Ratio Rank
The Martin Ratio Rank of High Beta - Max Sharpe Optimization is 66
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for High Beta - Max Sharpe Optimization, currently valued at 0.82, compared to the broader market-6.00-4.00-2.000.002.004.000.821.84
The chart of Sortino ratio for High Beta - Max Sharpe Optimization, currently valued at 1.34, compared to the broader market-6.00-4.00-2.000.002.004.006.001.342.48
The chart of Omega ratio for High Beta - Max Sharpe Optimization, currently valued at 1.16, compared to the broader market0.501.001.501.161.34
The chart of Calmar ratio for High Beta - Max Sharpe Optimization, currently valued at 1.25, compared to the broader market0.002.004.006.008.0010.0012.001.252.79
The chart of Martin ratio for High Beta - Max Sharpe Optimization, currently valued at 2.85, compared to the broader market0.0010.0020.0030.0040.002.8511.42
High Beta - Max Sharpe Optimization
^GSPC

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
LLY
Eli Lilly and Company
0.841.331.171.092.56
NVO
Novo Nordisk A/S
-0.73-0.870.88-0.59-1.42
ACGL
Arch Capital Group Ltd.
0.811.241.161.002.50
AVGO
Broadcom Inc.
1.542.241.313.459.53
NVDA
NVIDIA Corporation
1.582.131.273.319.51
SMCI
Super Micro Computer, Inc.
-0.43-0.021.00-0.58-0.97
ELF
e.l.f. Beauty, Inc.
-0.66-0.760.91-0.73-1.28

The current High Beta - Max Sharpe Optimization Sharpe ratio is 0.48. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 1.27 to 2.01, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests that it may not be performing as well in terms of risk-adjusted returns compared to many other portfolios. The lower performance could be due to either lower returns, higher volatility, or a combination of both. This might indicate that the portfolio requires some fine-tuning. You can use the Portfolio Optimization tool to find an allocation that maximizes the Sharpe ratio.

Use the chart below to compare the Sharpe ratio of High Beta - Max Sharpe Optimization with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50SeptemberOctoberNovemberDecember2025February
0.82
1.84
High Beta - Max Sharpe Optimization
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

High Beta - Max Sharpe Optimization provided a 1.74% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio1.74%1.73%0.70%0.96%1.00%1.39%1.59%1.78%1.62%2.28%1.33%1.73%
LLY
Eli Lilly and Company
0.64%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%
NVO
Novo Nordisk A/S
1.75%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%
ACGL
Arch Capital Group Ltd.
5.37%5.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
1.00%0.94%1.71%3.02%2.24%3.05%3.54%4.48%1.87%1.43%1.13%1.22%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%
SMCI
Super Micro Computer, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ELF
e.l.f. Beauty, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-20.24%
-2.03%
High Beta - Max Sharpe Optimization
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the High Beta - Max Sharpe Optimization. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the High Beta - Max Sharpe Optimization was 27.99%, occurring on Mar 23, 2020. Recovery took 52 trading sessions.

The current High Beta - Max Sharpe Optimization drawdown is 20.73%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-27.99%Feb 20, 202023Mar 23, 202052Jun 5, 202075
-22.48%Jul 11, 202420Aug 7, 2024
-19.55%Dec 28, 2021188Sep 26, 202242Nov 23, 2022230
-16.01%Oct 3, 201857Dec 24, 201845Mar 1, 2019102
-14.71%Mar 8, 202430Apr 19, 202424May 23, 202454

Volatility

Volatility Chart

The current High Beta - Max Sharpe Optimization volatility is 12.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
12.26%
4.05%
High Beta - Max Sharpe Optimization
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

ACGLLLYNVOELFSMCINVDAAVGO
ACGL1.000.200.180.240.240.180.22
LLY0.201.000.430.170.190.200.23
NVO0.180.431.000.170.210.250.24
ELF0.240.170.171.000.300.290.30
SMCI0.240.190.210.301.000.390.38
NVDA0.180.200.250.290.391.000.63
AVGO0.220.230.240.300.380.631.00
The correlation results are calculated based on daily price changes starting from Sep 23, 2016
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab